Circulating Biomarkers by Functional Domain
Click a topic to learn more
Biomarkers are used to assess pathway-specific metabolites, such as those that represent disease activity. For example, lipidomic markers can indicate stages of NAFLD or NASH.
Biomarkers, such as TGF-β1, CRP and others, are used to assess inflammatory activity levels, which may indicate disease activity or risk of progression.
Biomarkers are used to capture tissue-specific markers of fibrogenesis and fibrolysis. Some examples are the ELF panel, FIB-4, and various collagen precursors, such as PRO-C3.
Genomic biomarkers, such as PNPLA3 and TM6SF2, are increasingly used to enrich clinical study populations for genotypes associated with certain disease phenotypes.
To learn more about circulating and functional biomarkers and clinical R&D services for single and multi-site studies, contact firstname.lastname@example.org.